Application of real-time global media monitoring and ‘derived questions’ for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines

Overview of attention for article published in BMC Medicine, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 16 X users

facebook: 4 Facebook pages

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 93 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 4 public wall posts from 4 users.

UK Association of HPV Vaccine Injured Daughters, 02 Jun 2017

In November 2015, the EMA (European Medicines Agency) announced PRAC found no reason to alter the risk/benefit profile of HPV…

SANEVAX, 01 Jun 2017

In November 2015, the EMA (European Medicines Agency) announced PRAC found no reason to alter the risk/benefit profile of HPV…

Vaccination Information Network (VINE), 01 Jun 2017

European Medicines Agency monitoring vaccine media

Ghost Ship Media, 01 Jun 2017

HPV VACCINE STUDY: "Global Media Monitoring" Should Be Routine Part of Surveillance for Vaccines